Targeting chronic inflammation: Prof. Dr. Eicke Latz starts at Charité and German Rheumatism Research Centre

New Professor of Experimental Rheumatology and Scientific Director of the DRFZ

The Charité – Universitätsmedizin Berlin appointed Prof. Dr. Eicke Latz as Professor of Experimental Rheumatology on 1 May. He simultaneously became the new Scientific…

3 Min
More

An international team led by Charité – Universitätsmedizin Berlin has constructed the largest cellular proteomic map to date, using yeasts as model organisms

A proteome is the entirety of all active protein molecules present within an organism, a certain type of tissue, or a cell under specific conditions and at a certain time. Now, an international team of researchers led by members from Charité –…

4 Min
More

3B Pharmaceuticals from Berlin announced licensing agreement with Novartis Innovative Therapies

 

Berlin, April 24, 2023 – 3B Pharmaceuticals GmbH (3BP), a private German biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications, today announced that it has entered into an amended and restated…

2 Min
More

Eckert & Ziegler Receives Manufacturing Authorization for GMP-grade Lutetium-177

Berlin, 20 April 2023 - Eckert & Ziegler Radiopharma GmbH, a subsidiary of Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), has received the manufacturing authorization for Lutetium-177 (non-carrier-added Lu-177) in GMP…

2 Min
More

FDA Approval for BIOTRONIK’s Prospera™ Spinal Cord Stimulation System

Global Leader in Cardiac Rhythm Technology Solutions Expands Therapies for the Treatment of Chronic Intractable Pain with a New Approach to Managing Spinal Cord Stimulation

3 Min
More

Cellphenomics’ And Kyan Therapeutics Combined Platforms Provide Best-In-Class Solutions To Support The Biopharma Industry

Berlin/Singapore (April 14, 2023)

 

3 Min
More

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

Berlin, Germany and Zurich, Switzerland – April 12, 2023

 

3 Min
More

Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline

New investors, Andera Partners and Earlybird Venture Capital, join existing investor, Pureos Bioventures raising an additional EUR 22.75 million

Funds will be used to advance clinical pipeline and further build Ariceum Therapeutics

Olivier Litzka…

6 Min
More

Interview | Ryan Guterman, CEO and Founder at FaradaIC Sensors GmbH

Be prepared to learn new things constantly

3 Min
More

FALLING WALLS GLOBAL CALL 2023

Deadline: May 1st, 2023

BREAKTHROUGH RESEARCH WAS AND IS THE KEY TO UNDERSTANDING AND SOLVING THE GREATEST CHALLENGES OF OUR TIME

1 Min
More
Show more items